Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 856-859

  El Beitune, Patrícia ^a,b   Duarte, Geraldo ^a   Foss, Milton C ^a   Montenegro Jr , Renan M ^a   Quintana, Silvana M ^a   Figueiró Filho, Ernesto A ^a   Nogueira, Antonio A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b USP ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADOLESCENT; ADULT; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NEWBORN; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BLOOD GLUCOSE; COHORT STUDIES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INSULIN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; ZIDOVUDINE;

EID: 15944395144     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.856     Document Type: Article

References (14)

1. Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM, Weber K, Piessens E, Robison E, Anastos K: Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 32:298-302, 2003
2. AACTG: AACTG recommendations for metabolic problems: guide covers insulin resistance and diabetes. Aids Alert 18:6-9, 2003
3. El Beitune P, Duarte G, Quintana SM, Figueiró-Filho EA, Marcolin AC, Abduch R: Antiretroviral therapy during pregnancy and early neonatal life: conse quences for HIV-exposed, uninfected children. Braz J Infect Dis 8:140-150, 2004
4. Cunningham CK, Charbonneau TT, Song K, Patterson D, Sullivan T, Cummins T, Poiesz B: Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J 18:30-35, 1999
5. Dube MP, Johnson DL, Curnier JS, Leedom JM: Protease inhibitor-associated hyperglycemia. Lancet 350:713-714, 1997
6. Berkowitz GS, Lapinski RH, Wein R, Lee D: Racial/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135:965-973, 1992
7. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 23 (Suppl. 1):S77-S79, 2000
8. Grinspoon SK, Bilezikian JP: HIV disease and the endocrine system. N Engl J Med 327:1360-1365, 1992
9. Masharani U, Schambelan M: The endocrine complications of acquired immunodeficiency syndrome. Adv Intern Med 38: 323-336, 1993
10. Danoff A: Endocrinologic complications of HIV infection. Med Clin North Am 80: 1453-1469, 1996
11. Figueiró-Filho EA, El Beitune P, Rudge MVC, Quintana SM, Marcolin AC, Duarte G: Effects of antiretroviral drugs on glucide metabolism and pancreatic langerhans' cells of pregnant Wistar rats. Rev Bras Ginecol Obstet 26:369-375, 2004
12. Perinatal HIV Guidelines Working Group Members: Public Health Service Task Force recommendation for safety and toxicity of individual antiretroviral agents in pregnancy [article online], 2004. Available from http://www.hivatis. org. Accessed 25 March 2004
13. Koster JC, Remedi MS, Qiu H, Nichols CG, Hruz PW: HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 52:1695-1700, 2003
14. Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE: Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52:918-925, 2003